""

Spinalioma

Recruiting after consultation
Open recruiting

Neoadjuvant Therapy

There are currently no studies available

Adjuvant Therapy

Title: A Randomized, Placebo-Controlled, Double-Blind Study of Adjuvant Cemiplimab Versus Placebo After Surgery and Radiation Therapy in Patients With High Risk Cutaneous Squamous Cell Carcinoma
Phase: III
Contact: Silvia Koerner / Study Nurse
Clinical Investigator: Prof. Dr. Jessica Hassel
Registration: Die Studie ist bei den U.S. National Institutes of Health(ClinicalTrials.gov) registriert. Siehe NCT03969004
EudraCT-Number: (siehe EU klinisches Studienregister) 2019-000566-38

Metastatic Disease: First-Line-Therapy

Title: A single arm phase II, open-label, multicenter trial to investigate the clinical activity and safety of avelumab in combination with cetuximab in subjects with unresectable stage III or stage IV cutaneous squamous cell carcinoma (cSCC)
Phase: II
Contact: Melanie Leierer / Study Nurse
Clinical Investigator: Prof. Dr. Jessica Hassel
Registration: Keine Registernummer angegeben.
EudraCT-Number: (siehe EU klinisches Studienregister) 2018-001708-12

Metastatic Disease: Follow-Up Care

There are currently no studies available

Surgical Study

There are currently no studies available

Radiotherapy Study

There are currently no studies available

Other study

There are currently no studies available